Literature DB >> 2393053

Treatment of rectal carcinoid tumors.

K Shirouzu1, H Isomoto, T Kakegawa, M Morimatsu.   

Abstract

We investigated the treatment of 24 rectal carcinoid tumors from both the clinicopathologic and prognostic viewpoints. All tumors less than 2 cm in diameter had neither muscle layer invasion nor lymph node metastasis, except for an atypical carcinoid tumor that had both lymphatic permeation and intramural metastasis. One typical carcinoid tumor larger than 2 cm had both several lymphatic permeations and urinary bladder invasion. All cases had a good prognosis with no recurrence and no new metastases. For rectal carcinoid tumors less than 2 cm in diameter, local resection is sufficient, whereas radical operation is required for tumors larger than 2 cm in diameter. For atypical rectal carcinoid tumors, radical operation should be considered even if the diameter is less than 2 cm.

Entities:  

Mesh:

Year:  1990        PMID: 2393053     DOI: 10.1016/s0002-9610(06)80019-x

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  16 in total

1.  Successful outcomes of EMR-L with 3D-EUS for rectal carcinoids compared with historical controls.

Authors:  Tsuyoshi Abe; Tadayoshi Kakemura; Sumio Fujinuma; Iruru Maetani
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

2.  Disseminated rectal carcinoid tumor with production of immunoreactive motilin.

Authors:  Knut Grönstad; Lars Grimelius; Rolf Ekman; Jan Kewenter; Håkan Ahlman
Journal:  Endocr Pathol       Date:  1992-12       Impact factor: 3.943

3.  The Ki-67 labeling index and lymphatic/venous permeation predict the metastatic potential of rectal neuroendocrine tumors.

Authors:  Shinya Sugimoto; Kinichi Hotta; Tadakazu Shimoda; Kenichiro Imai; Yuichiro Yamaguchi; Takashi Nakajima; Takuma Oishi; Keita Mori; Kohei Takizawa; Naomi Kakushima; Masaki Tanaka; Noboru Kawata; Hiroyuki Matsubayashi; Hiroyuki Ono
Journal:  Surg Endosc       Date:  2015-12-30       Impact factor: 4.584

4.  Clinical efficacy of video-assisted gasless transanal endoscopic microsurgery (TEM) for rectal carcinoid tumor.

Authors:  Y Araki; H Isomoto; K Shirouzu
Journal:  Surg Endosc       Date:  2000-12-12       Impact factor: 4.584

5.  Transanal endoscopic microsurgery for the treatment of well-differentiated rectal neuroendocrine tumors.

Authors:  Hyoung Ran Kim; Woo Yong Lee; Kyung Uk Jung; Hyuk Jun Chung; Chul Joong Kim; Hae-Ran Yun; Yong Beom Cho; Seong Hyeon Yun; Hee Cheol Kim; Ho-Kyung Chun
Journal:  J Korean Soc Coloproctol       Date:  2012-08-31

6.  Usefulness of transanal endoscopic surgery for carcinoid tumor in the upper and middle rectum.

Authors:  K Ishikawa; T Arita; K Shimoda; Y Hagino; N Shiraishi; S Kitano
Journal:  Surg Endosc       Date:  2005-05-26       Impact factor: 4.584

7.  Gasless, video endoscopic transanal excision for carcinoid and laterally spreading tumors of the rectum.

Authors:  T Nakagoe; H Ishikawa; T Sawai; T Tsuji; M Jibiki; A Nanashima; H Yamaguchi; T Yasutake
Journal:  Surg Endosc       Date:  2003-05-13       Impact factor: 4.584

8.  Carcinoid and neuroendocrine tumors of the colon and rectum.

Authors:  T Philip Chung; Steven R Hunt
Journal:  Clin Colon Rectal Surg       Date:  2006-05

9.  Viability of endoscopic and excisional treatment of early rectal carcinoids.

Authors:  Anders Merg; Debrah Wirtzfeld; Jiping Wang; Richard Cheney; Kelli Bullard Dunn; Ashwani Rajput
Journal:  J Gastrointest Surg       Date:  2007-07       Impact factor: 3.452

10.  Endoscopic mucosal resection with circumferential mucosal incision of duodenal carcinoid tumors.

Authors:  Yuzo Otaki; Kiyoaki Homma; Yoshitakata Nawata; Kazuomi Imaizumi; Shigeru Arai
Journal:  World J Gastrointest Endosc       Date:  2013-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.